Keyword Analysis & Research: istari oncology

Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
istari oncology0.480.969935415
istari0.580.2215826
oncology0.090.72179148

Keyword Research: People who searched istari oncology also searched

Keyword CPC PCC Volume Score
istari oncology1.91693171
istari oncology stock0.810.7259163
istari oncology inc1.890.4431054

Search Results related to istari oncology on Search Engine

  • Istari Oncology

    istarioncology.com

    https://www.istarioncology.com/

    WEBOctober 18, 2022. Istari Oncology Announces Presentation of Clinical Responses from LUMINOS-102, an ongoing Phase 2 Trial of Lerapolturev in anti-PD-1 Refractory Metastatic Melanoma at the Society for Melanoma Research (SMR) 2022 Congress. During 2022.

    DA: 81 PA: 9 MOZ Rank: 69

  • Who We Are | Istari Oncology

    istarioncology.com

    https://www.istarioncology.com/about-us/who-we-are

    WEBIstari Oncology, Inc., is a clinical-stage biotechnology company developing innovative immunotherapies for the treatment of patients with solid tumors. Istari has built a passionate and experienced leadership team focused on clinical trial strategy and driving execution while seeking opportunities for partnership and collaboration with the ...

    DA: 43 PA: 74 MOZ Rank: 13

  • Management Team | Istari Oncology

    istarioncology.com

    https://www.istarioncology.com/about-us/management-team

    WEBMatthew R. Stober is the President and Chief Executive Officer of Istari Oncology. With more than 30 years of leadership experience at large, multinational pharmaceutical organizations, Mr. Stober has led multiple strategic corporate transactions, including major acquisitions and divestitures.

    DA: 76 PA: 4 MOZ Rank: 41

  • Istari Oncology | LinkedIn

    linkedin.com

    https://www.linkedin.com/company/istari-oncology

    WEBIstari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The...

    DA: 2 PA: 94 MOZ Rank: 75

  • Istari Oncology Announces FDA Grants Orphan Drug Designation …

    duke.edu

    https://otc.duke.edu/news/istari-oncology-announces-fda-grants-orphan-drug-designation-for-pvsripo/

    WEBDURHAM, NC, January 10, 2021 – Istari Oncology, Inc., a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for PVSRIPO for the treatment of advanced melanoma (stage IIB …

    DA: 26 PA: 56 MOZ Rank: 45

  • Istari Oncology Announces FDA Granted Fast Track Designation …

    businesswire.com

    https://www.businesswire.com/news/home/20210614005220/en/Istari-Oncology-Announces-FDA-Granted-Fast-Track-Designation-to-PVSRIPO-for-the-Treatment-of-Advanced-Melanoma

    WEBJun 14, 2021 · Istari Oncology, Inc., headquartered in Research Triangle Park, North Carolina, is a privately held clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy...

    DA: 63 PA: 83 MOZ Rank: 96

  • Istari Oncology Announces Publication of Phase 1 Data Showing …

    businesswire.com

    https://www.businesswire.com/news/home/20210421005855/en/Istari-Oncology-Announces-Publication-of-Phase-1-Data-Showing-PVSRIPO-Immunotherapy-Leads-to-Objective-Responses-in-Patients-with-Treatment-Refractory-Melanoma

    WEBApr 21, 2021 · Istari Oncology, Inc., headquartered in Research Triangle Park, North Carolina, is a privately held clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy...

    DA: 47 PA: 70 MOZ Rank: 41

  • Istari Oncology Enters Into Manufacturing Agreement With

    globenewswire.com

    https://www.globenewswire.com/news-release/2021/10/26/2320811/0/en/Istari-Oncology-Enters-Into-Manufacturing-Agreement-With-FUJIFILM-Diosynth-Biotechnologies-to-Advance-its-Viral-Immunotherapy-PVSRIPO.html

    WEBOct 26, 2021 · College Station, TX and Durham, NC, Oct. 26, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies (FDB) and Istari Oncology today announced that they have entered into an agreement for...

    DA: 78 PA: 40 MOZ Rank: 71

  • Duke spin-out Istari Oncology raises stakes for polio-based …

    bizjournals.com

    https://www.bizjournals.com/triangle/news/2021/08/24/istari-oncology-expands-range-of-cancer-treatments.html

    WEBAug 24, 2021 · |. Matt Stober, CEO of Durham's Istari Oncology. C/O Istari Oncology. By Lauren Ohnesorge – Senior Staff Writer, Triangle Business Journal. Aug 24, 2021. The pieces are starting to fall into...

    DA: 4 PA: 39 MOZ Rank: 42

  • Istari Oncology, Inc — Duke OTC

    duke.edu

    https://otc.duke.edu/startups/istari-oncology-inc/

    WEBISTARI Oncology is developing a glioblastoma treatment that uses a modified poliovirus to target cancer cells. Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors.

    DA: 32 PA: 94 MOZ Rank: 98